Recall: D-66295-001

Class II - Potentially Harmful

Class IIClassification

2013-09-05Initiated

TerminatedStatus

Hospira Inc.Firm

Product

0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 10 mL, Single-Dose Vial, NDC 0409-9045-01, Hospira, Inc., Lake Forest, IL 60045

Reason

Lack of Assurance of Sterility; potential for vial breakage

Distribution

Nationwide and Guam and Abu Dhabi

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.